| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/27/2006 | US20060167034 Novel benzonaphthyridines |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166941 Treatment and/or prevention of non-viral epithelial damage |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166934 Composition comprising phytosphingosine derivatives for apoptosis induction |
| 07/27/2006 | US20060165819 Topical composition for the treatment of psoriasis and related skin disorders |
| 07/27/2006 | US20060165815 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 07/27/2006 | US20060165813 Topical composition for treatment of skin disorders |
| 07/27/2006 | US20060165761 Wound dressings comprising vanadate complexed with organic ligands |
| 07/27/2006 | US20060165744 Combination liposomal formulations |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165688 Remedies for pemphigus containing cd40l antogonist as the active ingredient |
| 07/27/2006 | US20060165643 Cosmetic or dermopharmaceutical compositions containing kombucha |
| 07/27/2006 | US20060165630 Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin |
| 07/27/2006 | US20060165619 Cosmetic composition for skin whitening comprising senkyunolide A as active ingredient |
| 07/27/2006 | US20060165607 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/27/2006 | CA2592172A1 Modulators of itch ubiquitinase activity |
| 07/26/2006 | EP1683796A1 Pyrazolopyridines, their preparation and their medical use |
| 07/26/2006 | EP1682164A2 Cytokine antagonist molecules |
| 07/26/2006 | EP1682158A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 07/26/2006 | EP1682121A1 Use of crth2 antagonist compounds in therapy |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1507543A4 A pharmaceutical composition for treatment of wounds containing blood plasma or serum |
| 07/26/2006 | EP1448552B1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 07/26/2006 | EP1397105B1 Compositions for inhibiting angiogenesis |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1359905B1 Use of mglur5 antagonists for the treatment of pruritic conditions |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1192950B1 Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient |
| 07/26/2006 | EP1162937B1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
| 07/26/2006 | CN2798943Y Cicatrix plaster |
| 07/26/2006 | CN1809570A [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 07/26/2006 | CN1809530A Haloalkyl containing compounds as cysteine protease inhibitors |
| 07/26/2006 | CN1809367A A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 07/26/2006 | CN1809363A Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
| 07/26/2006 | CN1807463A White fungus heteropolysaccharide and its extract, preparation method and uses |
| 07/26/2006 | CN1806839A Preparation method of dragon's blood abnormity tablet and dragon's blood abnormity coating tablet |
| 07/26/2006 | CN1806831A Medicine for treating psoriasis and its preparing process |
| 07/26/2006 | CN1806825A Ointment for treating beriberi |
| 07/26/2006 | CN1806824A Almond sulfur cream |
| 07/26/2006 | CN1806798A Medicinal composition making bexarotene as active ingredients, its preparation method and use |
| 07/26/2006 | CN1806680A Oxidation resistance healthcare food and its preparation method |
| 07/26/2006 | CN1266149C Use of aspergillus fumigatus in preparing anti inflammatory immunosuppressant |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1266126C Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/26/2006 | CN1265832C External used medicines for Hong Kong foot and tinea manum |
| 07/26/2006 | CN1265822C Medicine for treating superficial and deep burn and scald |
| 07/26/2006 | CN1265804C Medicine for treating burns and scalds and its preparation |
| 07/26/2006 | CN1265800C Process for producing biopreparation with special acne, comedo and folliculitis treatment effect |
| 07/26/2006 | CN1265792C Use of niacin alkyl ester containing alkyl chain with 8 to 22 carbon atom in preparation of medicine for increasing leptin |
| 07/26/2006 | CN1265790C Anti-fungal remedy formulation for external application |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081479 Treatment of acne using alkonolamine compositions |
| 07/25/2006 | US7081476 Tocopherol enriched compositions for reducing IL6 levels |
| 07/25/2006 | US7081469 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081345 For use in diagnostic, prognostic, prophylactic or therapeutic formulation |
| 07/25/2006 | US7081259 Herbal, extract having therapeutic activity on injuries, and pharmaceutical composition and health food containing the same |
| 07/25/2006 | US7081258 Composition for promoting hair growth |
| 07/25/2006 | US7081254 For relieving or improving skin roughness and suppressing wrinkling, shows neither any offensive smell nor stickiness, gives users a dry feel upon use, and exhibits controlled foaming upon production and stability |
| 07/25/2006 | US7081240 Protein mixtures for wound healing |
| 07/25/2006 | CA2289209C Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof |
| 07/25/2006 | CA2283663C Benzocycloheptathiophene compounds |
| 07/25/2006 | CA2242354C Pyrrolopyrimidines and processes for their preparation |
| 07/25/2006 | CA2178107C Compositions for topical application to skin, hair or nails |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/20/2006 | WO2006075350A2 Use of the pof1 gene product for cosmetic and/or therapeutic use of skin associated disorders |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074928A2 Topical product for preventing and treating nappy rash |
| 07/20/2006 | WO2005120487A3 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
| 07/20/2006 | US20060159782 Material for promoting skin basement formation |
| 07/20/2006 | US20060159761 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine |
| 07/20/2006 | US20060159714 Use of an antioxidant in a dermatological and/or cosmetic composition |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | DE102005001645A1 Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis A topical product for the prevention and treatment of diaper rash |
| 07/20/2006 | CA2594798A1 Il-10 related peptides for wound healing |
| 07/20/2006 | CA2593697A1 Pan-her antagonists and methods of use |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681062A1 Antibacterial drug for propionibacterium acnes |
| 07/19/2006 | EP1680413A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 07/19/2006 | EP1680395A2 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 07/19/2006 | EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |